Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
27.68
+0.60 (2.22%)
Apr 29, 2026, 5:29 PM CET

Hansa Biopharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
676.46701.08405.28732.061,496651.34
Upgrade
Short-Term Investments
-----237.62
Upgrade
Cash & Short-Term Investments
676.46701.08405.28732.061,496888.96
Upgrade
Cash Growth
170.37%72.99%-44.64%-51.07%68.31%-35.47%
Upgrade
Accounts Receivable
70.1653.8726.7878.0342.969.71
Upgrade
Other Receivables
41.6318.2117.4915.7324.2213.53
Upgrade
Receivables
111.872.0844.2793.7667.1823.24
Upgrade
Inventory
6.046.132.611.510.970.24
Upgrade
Prepaid Expenses
-3.472.843.063.523.34
Upgrade
Other Current Assets
-13.8512.2424.7636.8526.56
Upgrade
Total Current Assets
794.3796.61467.24855.151,605942.34
Upgrade
Property, Plant & Equipment
10.6713.3517.8827.0735.8441.71
Upgrade
Other Intangible Assets
234.2717.4120.4623.1726.0128.76
Upgrade
Long-Term Accounts Receivable
122.96126.25118.19---
Upgrade
Long-Term Deferred Charges
-213.15176.88112.6520.85-
Upgrade
Total Assets
1,1621,167800.641,0181,6871,013
Upgrade
Accounts Payable
54.2754.0637.6286.9762.4853.36
Upgrade
Accrued Expenses
91.1694.2397.89116.54100.3278.22
Upgrade
Current Portion of Long-Term Debt
-136.87----
Upgrade
Current Portion of Leases
6.328.287.687.57.176.89
Upgrade
Current Income Taxes Payable
2.111.832.711.60.6-
Upgrade
Current Unearned Revenue
--16.3341.4740.4324.96
Upgrade
Other Current Liabilities
64.99115.493.4566.9153.717.79
Upgrade
Total Current Liabilities
218.84410.66255.69320.99264.71171.22
Upgrade
Long-Term Debt
1,133790.531,065844.9762.6-
Upgrade
Long-Term Leases
2.5836.6814.3621.3328.49
Upgrade
Long-Term Unearned Revenue
1.631.61--29.547.02
Upgrade
Long-Term Deferred Tax Liabilities
0.250.260.170.370.410.43
Upgrade
Other Long-Term Liabilities
80.7949.7163.35.35.958.08
Upgrade
Total Liabilities
1,4371,2561,3901,1861,084255.24
Upgrade
Common Stock
-275.27101.7667.8155.0355.0346.34
Upgrade
Additional Paid-In Capital
-4,4573,4543,0833,0222,573
Upgrade
Retained Earnings
--4,644-4,110-3,303-2,471-1,860
Upgrade
Treasury Stock
--2.03-2.36-2.36-2.59-1.86
Upgrade
Comprehensive Income & Other
--2.030.94-0.410.010.13
Upgrade
Shareholders' Equity
-275.27-88.99-589.83-167.88602.91757.57
Upgrade
Total Liabilities & Equity
1,1621,167800.641,0181,6871,013
Upgrade
Total Debt
1,142938.671,079866.77791.0935.38
Upgrade
Net Cash (Debt)
-465.8-237.59-673.73-134.71705.09853.58
Upgrade
Net Cash Growth
-----17.40%-37.81%
Upgrade
Net Cash Per Share
-5.19-2.93-10.72-2.5615.7019.19
Upgrade
Filing Date Shares Outstanding
101.76101.7667.8152.6752.4444.47
Upgrade
Total Common Shares Outstanding
101.76101.7667.8152.6752.4444.47
Upgrade
Working Capital
575.46385.95211.56534.161,340771.12
Upgrade
Book Value Per Share
-2.70-0.87-8.70-3.1911.5017.03
Upgrade
Tangible Book Value
-509.54-106.4-610.29-191.05576.9728.81
Upgrade
Tangible Book Value Per Share
-5.01-1.05-9.00-3.6311.0016.39
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.